News
06-27-2012, 02:20 PM
A study in JAMA challenges the view that intravenous thrombolysis is a particularly risky procedure in stroke patients with subtherapeutic international normalized ratios.Licensed from Medwire news with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.
More... (http://www.news-medical.net/news/20120627/e28098Riskye28099-view-of-thrombolysis-in-subtherapeutic-warfarin-patients-disputed.aspx)
More... (http://www.news-medical.net/news/20120627/e28098Riskye28099-view-of-thrombolysis-in-subtherapeutic-warfarin-patients-disputed.aspx)